ACAN p.Ser930Ile
c.2789G>T · rs938608 · VCV1188886
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1852 | likely benign |
|---|---|---|
| REVEL | 0.04 | moderately benign-leaning |
| SaProt | LLR -9.26 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP -0.56 | GERP -2.7 |
| Regional constraint | o/e 1.00 | unconstrained · MANE · 19 kb · p 0.97 · regional, not allelic |
| Overall | ||
| CADD | 7.408 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Amishnot grpmax-eligible | 65.7% | 2 |
| European (non-Finnish)grpmax | 64.6% | 2 |
| Ashkenazi Jewishnot grpmax-eligible | 61.1% | 2 |
| Middle Eastern | 59.1% | 2 |
| Finnishnot grpmax-eligible | 58.8% | 2 |
| Remaining individualsnot grpmax-eligible | 58.3% | 2 |
| South Asian | 50.5% | 2 |
| African / African-American | 47.4% | 2 |
| Admixed American | 36.8% | 3 |
| East Asian | 21.2% | 5 |
Amish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ACAN
- Protein
- p.Ser930Ile
- Coding
- c.2789G>T
- MANE Select
- NM_001369268
- dbSNP
- rs938608
- Type
- single nucleotide variant
- Location
- chr15:88855374 (GRCh38)
- Gene constraint
- LOEUF 0.377 · pLI 1.00 (gnomAD)
- Structure
- AlphaFold pLDDT 53.32 · 4 PDB
- Residue 930
- a UniProt-annotated variant site (in); the 'disordered' region; the 'cs-1' region
Disease context
osteochondritis dissecans — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: spondyloepiphyseal dysplasia, Kimberley typespondyloepimetaphyseal dysplasia, aggrecan typeshort stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans
For Osteochondritis dissecans (Orphanet):
- Inheritance
- Not applicable
- Onset
- All ages
- Prevalence
- 1-5 / 10 000 (Europe)
Similar variants
- ACAN c.1733-2A>G Likely pathogenic ★★ same condition
- ACAN c.7302+1G>A Pathogenic/Likely pathogenic ★★ same condition
- ACAN p.Arg236Ter Pathogenic ★★ same condition
- ACAN p.Arg675Ter Pathogenic/Likely pathogenic ★★ same condition
- ACAN p.Asp2419Asn Likely pathogenic ★★ same condition
- ACAN p.Glu254Ter Pathogenic ★★ same condition
- ACAN p.Lys74Ter Pathogenic ★★ same condition
- ACAN p.Trp377Ter Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/acan-p-ser930ile (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown